Joseph Finkelstein, MD, PhD, FAMIA, FACMI is a Professor and Vice-Chair of Clinical Data Science and Telemedicine Informatics at the Department of Biomedical Informatics at the University of Utah. After obtaining an MD and PhD degree in Biomedical Cybernetics, Dr. Finkelstein completed a post-doctoral fellowship in Biomedical Informatics at Columbia University, where he also obtained MA degree in Biomedical Informatics. His primary area of expertise is biomedical informatics, with a particular focus on clinical data science and innovative health information technologies supporting chronic disease prevention and management. He served as the Director of Biomedical Data Science and Informatics Service (BDSIS) and Associate Director for Cancer IT in the Tisch Cancer Center at the Icahn School of Medicine at Mount Sinai for over 5 years, where he was responsible for aggregating and harmonizing multiple data sets from longitudinal studies and implementing informatics solutions for cancer clinical trials. He is currently a member of the Huntsman Cancer Center at the University of Utah. The following areas of his research are directly related to cancer care: (1) interactive tools to support cancer survivors; (2) clinical decision support tools to facilitate guideline-concordant cancer care; (3) development of harmonized data hubs for predictive cancer analytics. His prior research demonstrated the significant potential of telehealth applications for cancer rehabilitation. He served as a Principal Investigator of several randomized clinical trials assessing the impact of home-based telerehabilitation in older adults with chronic health conditions. His recent research is focused on AI-driven analytics of healthcare utilization patterns to facilitate early prostate cancer diagnosis and assessment of usability and acceptance of home-based telerehabilitation in patients with advanced genitourinary cancer. Dr. Finkelstein is the Principal Investigator of a randomized clinical trial aimed at assessing the impact of comprehensive telerehabilitation in rural cancer survivors receiving androgen deprivation therapy. With the increasing availability of mobile and wearable technologies, Dr. Finkelstein’s research is focused on combining artificial intelligence, and big data analytics with digital health resources to expand access of cancer patients to treatment modalities that can improve their quality of life.